Pacira BioSciences, Inc.

Historical 13F Holders

Symbol
PCRX
CUSIP
695127100
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 695127100 since 12/18/2024, largest first.

Filer % of Class Filed
BlackRock, Inc. 13G/A 15.2% 4/28/2025
Event 3/31/2025
Vanguard Portfolio Management LLC 13G 6.4% 5/1/2026
Event 3/31/2026
State Street Corp 13G 5.2% 8/7/2026
Event 6/30/2026
Vanguard Capital Management LLC 13G 5.2% 5/1/2026
Event 3/31/2026
Dimensional Fund Advisors LP 13G 5.1% 4/9/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Renaissance Technologies LLC 13G/A
4.98% 11/13/2025
Event 7/1/2025
Pacer Advisors, Inc. 13G/A
1.3% 5/2/2025
Event 3/31/2025
Millennium Management LLC 13G/A
0.7% 4/21/2025
Event 3/31/2025
Doma Perpetual Capital Management LLC 13D/A
0% 10/13/2026
Event 10/8/2026
Vanguard Group Inc 13G/A 0% 3/27/2026
Event 3/13/2026

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 13 359 k $9.14 M
2026 Q2 261 45.5 M $1.18 B
2026 Q1 245 43.6 M $986 M
2025 Q4 267 47.0 M $1.22 B
2025 Q3 246 48.4 M $1.25 B
2025 Q2 243 53.0 M $1.27 B
2025 Q1 246 50.6 M $1.26 B
2024 Q4 248 49.9 M $941 M
2024 Q3 256 52.1 M $785 M
2024 Q2 300 53.0 M $1.52 B
2024 Q1 289 50.6 M $1.48 B
2023 Q4 278 49.4 M $1.67 B
2023 Q3 273 47.5 M $1.46 B
2023 Q2 268 47.0 M $1.88 B
2023 Q1 278 46.4 M $1.89 B
2022 Q4 286 50.3 M $1.94 B
2022 Q3 287 50.5 M $2.69 B
2022 Q2 299 49.0 M $2.86 B
2022 Q1 316 49.7 M $3.79 B
2021 Q4 292 50.7 M $3.05 B
2021 Q3 271 49.2 M $2.75 B
2021 Q2 274 49.2 M $2.99 B
2021 Q1 284 49.8 M $3.49 B
2020 Q4 279 51.5 M $3.08 B
2020 Q3 268 48.3 M $2.90 B
2020 Q2 261 48.7 M $2.56 B
2020 Q1 243 47.0 M $1.58 B
2019 Q4 246 46.1 M $2.09 B
2019 Q3 229 45.4 M $1.73 B
2019 Q2 247 47.4 M $2.06 B
2019 Q1 227 41.7 M $1.59 B
2018 Q4 225 40.8 M $1.76 B
2018 Q3 214 42.0 M $2.07 B
2018 Q2 173 43.8 M $1.40 B
2018 Q1 189 44.0 M $1.37 B
2017 Q4 207 41.9 M $1.91 B
2017 Q3 202 43.7 M $1.64 B
2017 Q2 215 41.2 M $1.97 B
2017 Q1 225 42.2 M $1.92 B
2016 Q4 206 40.7 M $1.31 B
2016 Q3 203 40.3 M $1.38 B
2016 Q2 199 40.8 M $1.38 B
2016 Q1 197 44.4 M $2.35 B
2015 Q4 231 43.3 M $3.32 B
2015 Q3 191 43.8 M $1.82 B
2015 Q2 200 42.8 M $3.03 B
2015 Q1 217 40.4 M $3.59 B
2014 Q4 211 39.4 M $3.50 B
2014 Q3 221 39.1 M $3.79 B
2014 Q2 204 38.4 M $3.52 B
2014 Q1 172 35.3 M $2.47 B